2021 年五月测量月:印度血压筛查活动结果分析。

IF 1.7 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
European Heart Journal Supplements Pub Date : 2024-07-24 eCollection Date: 2024-06-01 DOI:10.1093/eurheartjsupp/suae059
Anuj Maheshwari, Narsingh Verma, Jalees Fatima, Ajoy Tewari, Jothydev Kesavdev, Preeti Singh Dhoat, Amrit Kaur, Amit Gupta, Saurabh Srivastava, Abhinav Verma, Shivangi Maheshwari, Sajid Ansari, Amitesh Aggarwal, Abhishek Srivastava, Vanshika Arora, Thomas Beaney, Jonathan Clarke, Neil R Poulter
{"title":"2021 年五月测量月:印度血压筛查活动结果分析。","authors":"Anuj Maheshwari, Narsingh Verma, Jalees Fatima, Ajoy Tewari, Jothydev Kesavdev, Preeti Singh Dhoat, Amrit Kaur, Amit Gupta, Saurabh Srivastava, Abhinav Verma, Shivangi Maheshwari, Sajid Ansari, Amitesh Aggarwal, Abhishek Srivastava, Vanshika Arora, Thomas Beaney, Jonathan Clarke, Neil R Poulter","doi":"10.1093/eurheartjsupp/suae059","DOIUrl":null,"url":null,"abstract":"<p><p>Raised blood pressure (BP) is the leading preventable risk factor for cardiovascular diseases that makes a major impact on early mortality and morbidity. Recognizing hypertension in the community, educating people about routine BP monitoring, and improving medication compliance are all important steps in detecting, controlling, and managing hypertension. During the course of 5 months, members of the Indian Society of Hypertension organized unique medical indoor and outdoor camps at 100 screening locations around India for the May Measurement Month (MMM) 2021 study. At every location, BP was measured three times, and a questionnaire was completed. Participants known to have hypertension before the study whether taking or not taking treatment were not included (not a normal pre-requisite for exclusion in MMM). The analysis included 15 045 participants in total. After calculating the average of the second and third BP measurements, 16.4% of participants were found to have hypertension based on ≥140/90 mmHg thresholds (2461 out of 15 045). 14.0% of females and 16.4% of males had hypertension. 16.4% of participants had undiagnosed hypertension and were not receiving treatment. The MMM screening campaign has the potential for identifying large numbers of people with undiagnosed hypertension and raising awareness of the importance of raised BP among the general public, medical professionals, policymakers, the government, and the media. Future BP screening campaigns should be larger in scope and involve follow-ups with past participants.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"26 Suppl 3","pages":"iii44-iii47"},"PeriodicalIF":1.7000,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267709/pdf/","citationCount":"0","resultStr":"{\"title\":\"May Measurement Month 2021: an analysis of blood pressure screening campaign results from India.\",\"authors\":\"Anuj Maheshwari, Narsingh Verma, Jalees Fatima, Ajoy Tewari, Jothydev Kesavdev, Preeti Singh Dhoat, Amrit Kaur, Amit Gupta, Saurabh Srivastava, Abhinav Verma, Shivangi Maheshwari, Sajid Ansari, Amitesh Aggarwal, Abhishek Srivastava, Vanshika Arora, Thomas Beaney, Jonathan Clarke, Neil R Poulter\",\"doi\":\"10.1093/eurheartjsupp/suae059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Raised blood pressure (BP) is the leading preventable risk factor for cardiovascular diseases that makes a major impact on early mortality and morbidity. Recognizing hypertension in the community, educating people about routine BP monitoring, and improving medication compliance are all important steps in detecting, controlling, and managing hypertension. During the course of 5 months, members of the Indian Society of Hypertension organized unique medical indoor and outdoor camps at 100 screening locations around India for the May Measurement Month (MMM) 2021 study. At every location, BP was measured three times, and a questionnaire was completed. Participants known to have hypertension before the study whether taking or not taking treatment were not included (not a normal pre-requisite for exclusion in MMM). The analysis included 15 045 participants in total. After calculating the average of the second and third BP measurements, 16.4% of participants were found to have hypertension based on ≥140/90 mmHg thresholds (2461 out of 15 045). 14.0% of females and 16.4% of males had hypertension. 16.4% of participants had undiagnosed hypertension and were not receiving treatment. The MMM screening campaign has the potential for identifying large numbers of people with undiagnosed hypertension and raising awareness of the importance of raised BP among the general public, medical professionals, policymakers, the government, and the media. Future BP screening campaigns should be larger in scope and involve follow-ups with past participants.</p>\",\"PeriodicalId\":11956,\"journal\":{\"name\":\"European Heart Journal Supplements\",\"volume\":\"26 Suppl 3\",\"pages\":\"iii44-iii47\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267709/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal Supplements\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/eurheartjsupp/suae059\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal Supplements","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartjsupp/suae059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

血压(BP)升高是心血管疾病的主要可预防风险因素,对早期死亡率和发病率有重大影响。在社区中识别高血压、对人们进行常规血压监测教育以及提高服药依从性都是发现、控制和管理高血压的重要步骤。在 5 个月的时间里,印度高血压学会成员在印度各地的 100 个筛查地点组织了独特的室内和室外医疗营,开展 2021 年五月测量月(MMM)研究。在每个地点都测量了三次血压,并填写了一份调查问卷。在研究之前已知患有高血压的参与者,无论是否正在接受治疗,均不包括在内(这不是 MMM 排除在外的正常前提条件)。分析共包括 15 045 名参与者。在计算第二次和第三次血压测量的平均值后,根据≥140/90 mmHg 的阈值,发现 16.4% 的参与者患有高血压(15 045 人中有 2461 人)。14.0%的女性和 16.4%的男性患有高血压。16.4%的参与者未确诊高血压,也未接受治疗。MMM 筛查活动有可能发现大量未确诊的高血压患者,并提高公众、医疗专业人员、决策者、政府和媒体对提高血压重要性的认识。今后的血压筛查活动应扩大范围,并对过去的参与者进行跟踪调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
May Measurement Month 2021: an analysis of blood pressure screening campaign results from India.

Raised blood pressure (BP) is the leading preventable risk factor for cardiovascular diseases that makes a major impact on early mortality and morbidity. Recognizing hypertension in the community, educating people about routine BP monitoring, and improving medication compliance are all important steps in detecting, controlling, and managing hypertension. During the course of 5 months, members of the Indian Society of Hypertension organized unique medical indoor and outdoor camps at 100 screening locations around India for the May Measurement Month (MMM) 2021 study. At every location, BP was measured three times, and a questionnaire was completed. Participants known to have hypertension before the study whether taking or not taking treatment were not included (not a normal pre-requisite for exclusion in MMM). The analysis included 15 045 participants in total. After calculating the average of the second and third BP measurements, 16.4% of participants were found to have hypertension based on ≥140/90 mmHg thresholds (2461 out of 15 045). 14.0% of females and 16.4% of males had hypertension. 16.4% of participants had undiagnosed hypertension and were not receiving treatment. The MMM screening campaign has the potential for identifying large numbers of people with undiagnosed hypertension and raising awareness of the importance of raised BP among the general public, medical professionals, policymakers, the government, and the media. Future BP screening campaigns should be larger in scope and involve follow-ups with past participants.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Heart Journal Supplements
European Heart Journal Supplements 医学-心血管系统
CiteScore
3.00
自引率
0.00%
发文量
575
审稿时长
12 months
期刊介绍: The European Heart Journal Supplements (EHJs) is a long standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal. Traditionally EHJs published a broad range of articles from symposia to special issues on specific topics of interest. The Editor-in-Chief, Professor Roberto Ferrari, together with his team of eminent Associate Editors: Professor Francisco Fernández-Avilés, Professors Jeroen Bax, Michael Böhm, Frank Ruschitzka, and Thomas Lüscher from the European Heart Journal, has implemented a change of focus for the journal. This entirely refreshed version of the European Heart Journal Supplements now bears the subtitle the Heart of the Matter to give recognition to the focus the journal now has. The EHJs – the Heart of the Matter intends to offer a dedicated, scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信